Micron Technology, Inc. · MU

BUY with a $1,250 base price target (+29.6%) and $1,220 probability-weighted target (+26.5%) over 12 months.

First coverage — baseline assumptions established. MU is no longer a simple “cheap memory cycle” call. TTM revenue is $90.3B, TTM net income is $50.5B, TTM free cash flow is $26.2B, and TTM gross margin is 72.6%. Fiscal Q3 2026 was extraordinary: $41.46B revenue, 84.6% GAAP gross margin, and $24.67 GAAP diluted EPS.

The investment case is that AI has made memory bandwidth and capacity strategic, and Micron’s HBM, data-center DRAM/NAND, and strategic customer agreements can create a higher profit floor than prior cycles. The valuation still looks modest on next-year EPS, but the stock is up massively and trades 68.8% above its 200-day SMA. Positioning should be core-plus-satellite: hold core exposure, but add only on pullbacks and trim if price outruns EPS revisions.

Key Metrics:

Recent Financial Performance: TTM revenue is $90.3B, up 167.0% YoY. TTM net income is $50.5B, and TTM EPS is approximately $44.3. Fiscal Q3 2026 revenue was $41.46B, up 346% YoY, driven by DRAM and NAND pricing and mix strength.

Free Cash Flow: TTM operating cash flow was $51.4B, capex was $25.3B, and free cash flow was $26.2B, for a 29.0% FCF margin and 2.4% FCF yield on the current market cap.

Cost Structure: Fiscal Q3 R&D was $1.32B and SG&A was $0.41B. Micron is not an AI software company; for Micron, the real strategic investment line is capex, manufacturing technology, packaging, and HBM process capability rather than software-style R&D intensity.

Outlook: The company guided fiscal Q4 2026 revenue to $50.0B ± $1.0B, gross margin around 86%, and non-GAAP EPS of $31.00 ± $1.00. That guidance is the near-term gate for whether current margins are a new structural plateau or a peak-cycle air pocket.

Micron’s balance sheet has improved dramatically during the upcycle. Current cash and investments are $30.1B, total debt is $6.4B, and net cash is $23.8B. Working capital is $47.2B, total assets are $134.1B, and shareholders’ equity is $100.7B.

The solvency risk is low. The balance-sheet risk is capital-cycle risk: if Micron invests heavily into capacity while AI memory demand normalizes, returns can compress quickly. For now, strategic customer agreements and customer demand visibility support the spending plan, but this must be monitored quarter by quarter.

Near-term catalysts:

• Fiscal Q4 2026 report: the most important gate is whether the company meets or exceeds $50B revenue and ~$31 non-GAAP EPS guidance.
• Management commentary on strategic customer agreements: duration, price floors, ceiling structures, take-or-pay enforcement, and customer mix.
• HBM4/HBM4E qualification updates for leading AI platforms.
• Further analyst estimate and price-target revisions after BMO, New Street, Needham, Stifel, Deutsche Bank, Citi, RBC, Wolfe, Morgan Stanley, Susquehanna, DA Davidson, Barclays, UBS, and BofA moved positively in recent months.

Medium-term catalysts:

• HBM4E volume production expected in calendar 2027.
• Whether NAND and enterprise SSD pricing remains tight as AI storage demand broadens beyond training clusters.
• U.S. and international fab expansion execution, including government incentives and environmental/permitting progress.

Event-driven catalysts:

• Any customer-specific AI server capex change from major hyperscalers and accelerator OEMs.
• China/CAC, Taiwan, tariffs, or export-control developments.
• Patent litigation outcomes involving Netlist, YMTC, AMT, Nextech, and other IP claimants.

Analyst Consensus: Finviz shows an analyst target price of $1,560.25 and a recommendation score of 1.26, implying very bullish sell-side sentiment.

PT-Revision Velocity: highly positive. The last 90 days included repeated upward revisions and initiations, including BMO at $1,300, New Street to Buy at $1,250, Needham to $1,650, Wedbush to $1,300, Stifel to $1,500, Deutsche Bank to $1,500, Citi to $1,200, RBC to $1,200, Wolfe to $1,250, Morgan Stanley to $1,050, Susquehanna to $1,750, DA Davidson to $1,500, Barclays to $1,175, UBS to $1,625, and BofA to $950. The ≥3 upward-revision threshold in 60 days is clearly met.

Probability-Weighted Target: $1,220.00.

Multiple-Expansion / Compression Decomposition:

Sensitivity: At base EPS of $156.25, every 1x change in the target multiple equals about $156 of share value, or roughly 16% of the current price. Multiple risk is therefore material even if earnings remain strong.

Multi-Horizon Checkpoints:

Red-Flag Pattern Count: 2/8.

Asymmetry Verdict: attractive but not clean. The upside is meaningful because earnings power may still be underestimated, and the balance sheet is strong. The downside is also large because the stock is technically extended and memory stocks can derate violently when investors sense peak pricing. The right expression is a disciplined BUY: hold core exposure, add on pullbacks, and actively trim satellite shares when price moves faster than EPS revisions.

Ranked Risks:

1. Memory cyclicality: The largest risk is that investors overpay for peak pricing and peak margin.
2. AI capex reflexivity: HBM and data-center memory demand is tied to AI infrastructure spending that can change quickly if ROI concerns rise.
3. Supply response: High margins attract capacity. Even disciplined suppliers can create future oversupply if customer demand flattens.
4. Strategic customer agreement opacity: Take-or-pay terms improve visibility, but public disclosure is limited and the disclosed remaining performance obligation base is small relative to annualized revenue.
5. Legal/IP risk: Netlist, YMTC, AMT, Nextech, and other patent disputes cover broad parts of DRAM/NAND/HBM products.
6. Geopolitical risk: China CAC restrictions, Taiwan manufacturing exposure, export controls, and tariffs can affect demand, supply chain, and customer relationships.
7. Project execution: U.S. and international manufacturing expansions carry permitting, incentive, labor, and capex-overrun risk.
8. Valuation/technical risk: The stock remains far above the 200-day SMA after a historic move.

Sizing Guidance: Treat MU as a high-volatility cyclical-growth hybrid. Core sizing is justified by AI memory scarcity and balance-sheet strength; satellite exposure should be governed by pullback levels, EPS revisions, and explicit trim rules.

Velocity Flag: neutral. The price is more than 30% above the 200-day SMA, but RSI is not above 75, so the formal overshoot rule is not triggered. The practical instruction is still disciplined: do not chase; add only on pullbacks.

Recent disclosed insider activity includes sales by the CEO, CFO, business-unit executives, people leadership, legal/accounting officers, and directors, alongside one notable director purchase by T. Mark Liu in January 2026. The overall read is mixed: institutional sponsorship is strong, but insider behavior is not an incremental bullish signal after the stock’s large move.

Recent news flow is fundamentally positive but tactically stretched. Micron reported record fiscal Q3 2026 results, guided to an even stronger Q4, highlighted HBM4 shipments and HBM4E development, and announced a planned $10B Micron Research Labs investment in Boise over the next decade.

Sell-side sentiment is highly positive, with multiple upgrades and target increases in the last 90 days. The negative sentiment thread is valuation and positioning: large funds trimming memory exposure, concerns about bond yields and AI-trade reversals, and debate over whether Micron is still a commodity cyclical or a structurally advantaged AI memory supplier.

No separate scored sentiment feed was available; this is a qualitative read.

Leadership and execution: Micron’s leadership has executed exceptionally through the current AI-memory cycle. The strongest evidence is operating: fiscal Q3 2026 revenue of $41.46B, GAAP gross margin of 84.6%, and GAAP diluted EPS of $24.67.

Governance structure: The board uses annual elections, majority voting, a Lead Independent Director, and a majority-independent board. The main governance tradeoff is that Sanjay Mehrotra serves as both Chair and CEO. That is acceptable given the operating record, but it raises succession and independent-oversight importance.

Board composition: The board has strong semiconductor, finance, technology, cyber, manufacturing, and public-company experience. Recent additions including Robert Swan, T. Mark Liu, and A. Christine Simons add relevant finance, semiconductor, audit, and manufacturing expertise.

Capital allocation:

The governance grade is A-: excellent execution and strong board expertise, offset by combined Chair/CEO structure and limited disclosed CEO succession detail.

Buzzword-Washing Score: 3/10

This is not a superficial AI pivot. Micron sells the memory and storage bottlenecks required by AI systems. The concern is that the stock market may capitalize a scarcity period as if it were permanent.

Dilution-to-Progress Ratio: favorable. Shares outstanding increased roughly 3% from FY2022 to May 2026, while revenue rose from $30.8B in FY2022 to $90.3B TTM and net income rose from $8.7B to $50.5B. Dilution is not the problem; the issue is whether today’s per-share earnings are cyclically inflated.

Micron repurchased $650M of stock in the first nine months of fiscal 2026 and paid dividends, but capital returns are secondary to capex and technology investment at this stage of the cycle.

Revenue quality has improved materially, but it is not yet equivalent to recurring software or contracted infrastructure revenue.

The grade is B+. Strategic agreements are a real upgrade to the memory business model, but the disclosure does not yet prove that Micron has fully escaped memory cyclicality.